Drug intelligence / Profile preview

Niagen Plus

Development stage
Phase 1
Lead developer
Niagen Bioscience
Modality
Small Molecules
Administration
Intravenous, Injection
01

Overview

Niagen Plus is a branded, pharmaceutical-grade nicotinamide riboside chloride (Niagen) product developed for intravenous and injectable administration to acutely raise nicotinamide adenine dinucleotide (NAD+) levels for wellness and longevity applications. It uses patented Niagen, a clinically studied form of nicotinamide riboside (a vitamin B3 derivative and NAD+ precursor), to increase circulating and cellular NAD+ more efficiently and with shorter infusion times than traditional NAD+ IV therapies, with pilot data showing up to ~20% NAD+ increase within 3 hours and improved tolerability. The product is supplied to clinics (including at-home injectable kits from partner pharmacies) for prescription-based IV drips, shots, or pushes, targeting cellular energy metabolism, mitochondrial function, and stress- or age-related NAD+ decline rather than a specific approved disease indication.[1][4][7][8][15][19]

Brand names
Niagen Plus
Other names
nicotinamide riboside chlorideNRClpharmaceutical-grade Niagen
02

Targets

CD38 (Cluster of Differentiation 38)

Beyond the preview

Go deeper on Niagen Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niagen Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call